百家乐怎么玩-澳门百家乐官网娱乐城网址_网上百家乐是不是真的_全讯网888 (中国)·官方网站

Mapping a biotech future in Hong Kong

Regina Lau

 

Recent biotech achievements in China offer immense opportunities for Hong Kong to enhance her position in biotechnology, one of the most promising industries for coming decades, said Professor Y L Lo, Founding Chairman of the Hong Kong Biotechnology Association, at CityU on 20 January. Professor Lo's lecture, "Biotechnology-the Catalyst of Hong Kong's Future Economic Development?" was the latest in the Distinguished Industrialist Lecture Series, organized by CityU's Faculty of Science and Engineering to foster closer links between the University community and the business sector. "Collaborating with China and participation in i

nternational biotech projects are crucial steps for Hong Kong to establish itself in this mega trend for the 21st century," he told the audience.

Professor Lo, who is also the President (Asia Pacific) of PerkinElmer Life and Sciences (Hong Kong) Limited, a US based biotech company, gave a comprehensive picture of biotech development in the Asia Pacific region, which is set to become the engine for global economic growth. Governments in Taiwan, Korea, Singapore and Japan have shown a clear commitment to expanding the biotech industry, which has also experienced booming investment from the private sector. With her growing contributions to the Human Genome Project, breakthroughs in decoding the hybrid rice genome, and production of recombinant drugs and vaccines, China is capable of becoming a future leader in the Asia biotech industry, he said.

"In Hong Kong, the biotech industry is currently very much trade-based. We are lagging behind our neighbors in terms of technological innovation and R&D investment," said Professor Lo. "But with a strong service base, heightened awareness among our entrepreneurs of the huge potential of the life science industry, and our position as China's bridge to the world, Hong Kong is well situated to find a niche in the booming biotech field."

The process of commercialization and technology transfer in biotechnology creates huge opportunities for various sectors, including the legal and fina

nce sectors. Instead of starting from scratch, Hong Kong should focus on the advanced stages of the process, Professor Lo said. "Immense opportunities in servicing and intellectual property protection at the advanced stage of the process are waiting to be explored." 

 

YOU MAY BE INTERESTED

Contact Information

Communications and Institutional Research Office

Back to top
百家乐官网娱乐平台备用网址| 百家乐官网游戏合法吗| 百家乐官网可以算牌么| 筹码百家乐官网的玩法技巧和规则 | 永利高官网| 百家乐官网翻天快播| 百家乐直杀| 百家乐官网水浒传| 百家乐下对子的概率| 澳门赌场筹码| 女优百家乐的玩法技巧和规则 | 百家乐赢足球博彩皇冠| 大发888网页游戏平台| 百家乐庄闲比率| 百佬汇百家乐的玩法技巧和规则 | 百家乐赢的技巧| 百家乐官网隔一数打投注法| bet365百科| 金钱豹百家乐的玩法技巧和规则| 百家乐官网如何打公式| 全讯网xb112| 百家乐官网赌的是心态吗| 开心8百家乐现金网| 百家乐官网官方网址| 致胜百家乐官网软件| 沂南县| 永利国际娱乐| 太阳城百家乐币| 百家乐官网的弱点| 博E百百家乐官网娱乐城| 真博娱乐| 赌博启示录| 大发888直播网| 金界百家乐的玩法技巧和规则| 注册百家乐官网送彩金| 丘北县| 百家乐单打| 信誉好百家乐平台| 百家乐官网评级网站| 澳门百家乐官网庄闲的玩法| 百家乐官网有没有绝|